You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Products:Cell Biology >> Apoptosis >> Nucleus >> PARP

Anti-Cleaved PARP antibody [4B5BD2] (ab110315)

MSCatalog No. MS777

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-Cleaved PARP antibody [4B5BD2]
See all Cleaved PARP products (10) ...

Description

Mouse monoclonal [4B5BD2] to Cleaved PARP

Specificity

ab110315 reacts with the N-terminal end formed by the cleavage adjacent to Asp214; it thus recognizes the apoptosis-specific 89 kDa catalytic domain fragment, but it does not recognize the full-length PARP-1 or the 24 kDa DNA binding domain fragment.

Tested applications

WB, ICC/IF, In-Cell ELISA, Flow Cytmore details

Cross reactivity

Reacts with

Human

Positive control

Staurosporine-treated HeLa and HL60 cells

Properties

Form

Liquid

Storage instructions

Store at +4°C. Do not freeze.

Storage buffer

Preservative: 0.02% Sodium azide
Constituent: HBS

Concentration

Concentration information loading...

Purity

Ammonium Sulphate Precipitation

Purification notes

The antibody was produced in vitro using hybridomas grown in serum-free medium, and then purified by ammonium sulfate precipiation.

Clonality

Monoclonal

Clone number

4B5BD2

Isotype

IgG1

Light chain type

kappa

  • Immunocytochemistry/ Immunofluorescence - Cleaved PARP antibody [4B5BD2] (ab110315)Immunocytochemistry/ Immunofluorescence - Cleaved PARP antibody [4B5BD2] (ab110315) image (enlarge)

  • Western blot - Anti-Cleaved PARP antibody [4B5BD2] (ab110315)Western blot - Anti-Cleaved PARP antibody [4B5BD2] (ab110315) image (enlarge)

  • In-Cell ELISA - Cleaved PARP antibody [4B5BD2] (ab110315)In-Cell ELISA - Cleaved PARP antibody [4B5BD2] (ab110315) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab110315 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks. Mediates the poly(ADP-ribosyl)ation of APLF and CHFR. Positively regulates the transcription of MTUS1 and negatively regulates the transcription of MTUS2/TIP150.

Sequence similarities

Contains 1 BRCT domain.
Contains 1 PARP alpha-helical domain.
Contains 1 PARP catalytic domain.
Contains 2 PARP-type zinc fingers.

Post-translational
modifications

Phosphorylated by PRKDC. Phosphorylated upon DNA damage, probably by ATM or ATR.
Poly-ADP-ribosylated by PARP2. Poly-ADP-ribosylation mediates the recruitment of CHD1L to DNA damage sites.
S-nitrosylated, leading to inhibit transcription regulation activity.

Cellular localization

Nucleus.

Target information above from: UniProt accessionP09874 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • ADPRT 1 antibody
  • ADPRT antibody
  • ADPRT1 antibody
  • APOPAIN antibody
  • MS777 antibody
  • NAD(+) ADP-ribosyltransferase 1 antibody
  • PARP antibody
  • PARP-1 antibody
  • PARP1 antibody
  • PARP1_HUMAN antibody
  • Poly [ADP-ribose] polymerase 1 antibody
  • Poly ADP ribose polymerase 1 antibody
  • Poly[ADP-ribose] synthase 1 antibody
  • PPOL antibody
  • SCA1 antibody
see all

Anti-Cleaved PARP antibody [4B5BD2] images:

  Immunocytochemistry/ Immunofluorescence - Cleaved PARP antibody [4B5BD2] (ab110315)

Immunocytochemistry/ Immunofluorescence - Cleaved PARP antibody [4B5BD2] (ab110315)

Immunocytochemistry images of stained untreated (A) and 4 hours 1 µM Staurosporine-treated (B) Human HeLa cells. The cells were paraformaldehyde fixed (4%, 20 minutes) and Triton X-100 permeabilized (0.1%, 15 minutes). The cells were incubated with 1.0 µg/ml ab110315 for 2 hours at room temperature or over night at 4°C. 10% goat serum was used as the blocking agent for all blocking steps. The secondary antibody was Alexa Fluor® 488 goat anti-mouse IgG (H+L) (in green) used at 2.0 µg/ml for 2 hours. DAPI was used to stain the cell nuclei (in red). Heat induced antigen retrieval (0.1 M Tris-HCl, 5% urea, pH 9.5 for 5 min at 95°C) improves signal. Note that the ab110315 labels only condensed and/or fragmented nuclei of apoptotic Staurosporine-treated cells.

  Western blot - Anti-Cleaved PARP antibody [4B5BD2] (ab110315)

Western blot - Anti-Cleaved PARP antibody [4B5BD2] (ab110315)

Lanes 1 - 2 : Antibody that recognizes full-length PARP1
Lanes 3 - 4 : Anti-Cleaved PARP antibody [4B5BD2] (ab110315) at 1 µg/ml

Lane 1 : untreated HeLa cells
Lane 2 : HeLa cells treated with 1 µM Staurosporinefor 4 hours
Lane 3 : untreated HeLa cells
Lane 4 : HeLa cells treated with 1 µM Staurosporinefor 4 hours

Lysates/proteins at 20 µg per lane.


Predicted band size : 113 kDa


Western Blot analysis using ab110315 antibody and 20 µg of untreated (CON) or 4 hours 1 µM Staurosporine-treated (STS) HeLa cells. Blots were incubated with an antibody that recognizes both the full-length PARP-1 and its 89 kDa fragment (left panel), or 1.0 µg/mL PARP-1 (cleaved) antibody (ab110315) (right panel). Appropriate HRP-conjugated secondary antibodies followed by ECL detection were used. Note that the MS777 antibody recognizes the apoptosis-specific 89 kDa fragment of PARP-1 but it does not recognize the full-length PARP-1.

  In-Cell ELISA - Cleaved PARP antibody [4B5BD2] (ab110315)

In-Cell ELISA - Cleaved PARP antibody [4B5BD2] (ab110315)

In-Cell ELISA (ICE) using ab110315 on HeLa cells treated with Staurosporine to induce apoptosis. HeLa cells were seeded overnight (50,000 cells/well), treated for 4 hours with 1 µM Staurosporine or with the drug vehicle (DMSO), fixed for Detaching Adherent Cells and analyze.

  Flow Cytometry - Cleaved PARP antibody [4B5BD2] (ab110315)

Flow Cytometry - Cleaved PARP antibody [4B5BD2] (ab110315)

Flow cytometry analysis of apoptosis using ab110315. HL-60 cells were treated with 1 µM Staurosporin for 4 hours (blue) or vehicle control (red). Control cells were also stained with an equal amount of an isotype control antibody (black).

References for Anti-Cleaved PARP antibody [4B5BD2] (ab110315)

ab110315 has not yet been referenced specifically in any publications.

Publishing research using ab110315? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"